Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 4
2008 5
2009 6
2010 4
2011 5
2012 3
2013 4
2014 10
2015 6
2016 7
2017 7
2018 11
2019 10
2020 10
2021 10
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Results by year
Filters applied: . Clear all
Page 1
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators. Caraceni P, et al. Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Lancet. 2018. PMID: 29861076 Clinical Trial.
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.
Caraceni P, Tufoni M, Zaccherini G, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Simone L, Svegliati-Baroni G, Fagiuoli S, Laffi G, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Gasbarrini A, De Marco R, Piano S, Nardelli S, Elia C, Roncadori A, Baldassarre M, Bernardi M; ANSWER Study Investigators. Caraceni P, et al. J Hepatol. 2021 Feb;74(2):340-349. doi: 10.1016/j.jhep.2020.08.021. Epub 2020 Aug 24. J Hepatol. 2021. PMID: 32853747 Clinical Trial.
KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
Raho S, Capobianco L, Malivindi R, Vozza A, Piazzolla C, De Leonardis F, Gorgoglione R, Scarcia P, Pezzuto F, Agrimi G, Barile SN, Pisano I, Reshkin SJ, Greco MR, Cardone RA, Rago V, Li Y, Marobbio CMT, Sommergruber W, Riley CL, Lasorsa FM, Mills E, Vegliante MC, De Benedetto GE, Fratantonio D, Palmieri L, Dolce V, Fiermonte G. Raho S, et al. Among authors: de leonardis f. Nat Metab. 2020 Dec;2(12):1373-1381. doi: 10.1038/s42255-020-00315-1. Epub 2020 Nov 23. Nat Metab. 2020. PMID: 33230296
Elderly-onset gout: a review.
De Leonardis F, Govoni M, Colina M, Bruschi M, Trotta F. De Leonardis F, et al. Rheumatol Int. 2007 Nov;28(1):1-6. doi: 10.1007/s00296-007-0421-7. Epub 2007 Jul 26. Rheumatol Int. 2007. PMID: 17653719 Review.
Paget's disease of bone: a review.
Colina M, La Corte R, De Leonardis F, Trotta F. Colina M, et al. Among authors: de leonardis f. Rheumatol Int. 2008 Sep;28(11):1069-75. doi: 10.1007/s00296-008-0640-6. Epub 2008 Jul 1. Rheumatol Int. 2008. PMID: 18592244 Review.
Non-Hermitian Sensing in Photonics and Electronics: A Review.
De Carlo M, De Leonardis F, Soref RA, Colatorti L, Passaro VMN. De Carlo M, et al. Among authors: de leonardis f. Sensors (Basel). 2022 May 24;22(11):3977. doi: 10.3390/s22113977. Sensors (Basel). 2022. PMID: 35684602 Free PMC article. Review.
Natural bioactive compounds against oxidative stress: dietary polyphenols strike back.
Arrigoni R, Cammarota F, Porro R, Cantore S, Dioguardi M, Cazzolla AP, De Leonardis F, Polimeno L, Zerman N, Di Cosola M, Mastrangelo F, Santacroce L, Ballini A. Arrigoni R, et al. Among authors: de leonardis f. Endocr Metab Immune Disord Drug Targets. 2022 Nov 7. doi: 10.2174/1871530323666221107092553. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 36345247
98 results